Navigation Links
BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year
Date:11/2/2011

p>$

288,541

$

282,9682.02.0-   International209,209160,39630.418.511.9TOTAL

$

497,750

$

443,36412.37.94.4BY SEGMENT   BD Medical

$

243,521

$

208,82216.612.44.2   BD Diagnostics254,229234,5428.44.04.4TOTAL

$

497,750

$

443,36412.37.94.4Twelve Months Ended September 30, % Change 20112010 Reported FXNFX ImpactTOTAL SAFETY REVENUES   United States

$

1,116,543

$

1,108,4310.70.7-   International754,739621,91321.413.67.8TOTAL

$

1,871,282

$

1,730,3448.15.42.7BY SEGMENT   BD Medical

$

885,156

$

819,0848.15.42.7   BD Diagnostics986,126911,2608.25.32.9TOTAL

$

1,871,282

$

1,730,3448.15.42.7Page 11BECTON DICKINSON AND COMPANYSUPPLEMENTAL INFORMATIONFY2011 Quarter-to-Date Reconciliation(Unaudited; Amounts in millions, except per share data)Three Months Ended September 30,ReportedImpairmentAdjustedReportedAdjustedFY 2011Charge (1)FY 2011FY 2010% GrowthDiluted Earnings per Sharefrom Continuing Operations

$

1.36

$

0.03

$

1.39

$

1.2412.1%(1) Represents a non-cash impairment charge resulting from the
discontinuance of a research program within the Diagnostic Systems unit.
All figures rounded. Totals may not add due to rounding.Page 12BECTON DICKINSON AND COMPANYSUPPLEMENTAL INFORMATIONFY2011 Year-to-Date Reconciliation(Unaudited; Amounts in millions, except per share data)Twelve Months Ended September 30,ReportedImpairmentAdjustedReportedAdjustedAdjustedFY 2011Charge (1)FY 2011FY 2010Tax (2)FY 2010% GrowthDiluted Earnings per Sharefrom Continuing Operations

$

5.59

$

0.03

$

5.62

$

4.90

$

0.04

$

4.9413.8%(1) Represents a non-cash impairment charge resulting from
'/>"/>

SOURCE BD (Becton, Dickinson and Company)
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Jazz Pharmaceuticals Announces Third Quarter 2011 Financial Results
2. Genomic Health Announces Third Quarter 2011 Financial Results and Business Progress
3. Quest Diagnostics Announces Launch of Simplexa™ Direct Test for Influenza and Respiratory Viruses in Europe
4. Perrigo Announces Launch of Generic Version of Elestat®
5. Telik Announces Ezatiostat (Telintra®) Preclinical Presentation at the 2011 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
6. CRC Health Group Announces Acquisition of North Carolinas Mountain Health Solutions
7. Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
8. Takeda Announces PDUFA Action Date for Investigational Type 2 Diabetes Therapies Alogliptin and the Fixed-Dose Combination Alogliptin/Pioglitazone
9. Medela Announces Virtual Breast Milk Collection Campaign in Honor of Prematurity Awareness Month
10. Rigel Announces Third Quarter 2011 Financial Results
11. Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Auxilium Pharmaceuticals, ... specialty biopharmaceutical company, today announced that the Company ... from its partner Asahi Kasei Pharma Corporation (Asahi ... successful submission of a regulatory application to the ... XIAFLEX ® (collagenase clostridium histolyticum) for the ...
(Date:7/30/2014)...  There is still time to share your ... Annual Institute for Supply Management ® – ... Management is open for submissions.  The annual competition ... of supply management by recognizing supply management organizations ... practices.  Entries are due August 22, 2014. ...
(Date:7/30/2014)... CryoLife, Inc. (NYSE: CRY), a leading medical ... vascular surgery, announced today that its Board of Directors ... quarter 2014 of $0.03 per share of common stock ... will be paid on September 19, 2014 to all ... The ex-dividend date for the quarterly dividend is September ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5Institute for Supply Management, Michigan State University to recognize companies with excellent supply management practices 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 2CryoLife Announces Quarterly Cash Dividend for the Third Quarter 2014 3
... II data show RAD001 significantly increased efficacy of, letrozole tablets in women with newly diagnosed hormone-positive ... cancer, ... ... breast cancer by ...
... Presented at ASCO Annual Meeting -, ... 1 /PRNewswire-FirstCall/,-- Poniard Pharmaceuticals, Inc. (Nasdaq: ... today announced safety and efficacy results,from a ... picoplatin and,liposomal doxorubicin in patients with advanced ...
Cached Medicine Technology:Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 2Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 3Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 4Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 5Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 6Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 7Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 8Early Data Presented at ASCO Show Potential of RAD001 to Enhance Efficacy of, and Overcome Resistance to, Breast Cancer Treatments 9Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 2Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 3Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 4Poniard Announces Positive Efficacy and Safety Data From Phase 1 Trial of Picoplatin in Multiple Tumor Types Including Ovarian Cancer 5
(Date:7/31/2014)... HealthDay Reporter WEDNESDAY, July ... boy" disease can often be cured with a stem cell ... critical, a new study finds. Severe combined immunodeficiency (SCID), ... group of rare genetic disorders that all but eliminate the ... infections. The term "bubble boy" became popular after a ...
(Date:7/31/2014)... 31, 2014 Recently, Agebc.com, a popular online ... revealed its new selection of trendy mother of the ... offered at promotional prices now, up to 68% off. , ... adding the new range of mother of the bride dresses. ... international clients. So far, our online shop has received thousands ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 A ... Heart Specialists is helping patients who have an ... is used for ablation procedures for patients such ... electrophysiologists at Baptist Heart Specialists were the ... new catheter this past spring, according to Biosense ...
(Date:7/31/2014)... 2014 Bedros Keuilian’s Fit Body Boot Camp ... other countries. At his annual Fitness Business Summits, some of ... their marketing strategies. But in his latest blog post, he ... marketing a personal training business is to create free ... personal trainer has a certain area that they really feel ...
(Date:7/31/2014)... Lauderdale, FL. (PRWEB) July 31, 2014 ... – USARAD Holdings Inc. a leading US Joint ... offers the most innovative and technologically advanced consumer ... SecondOpinions.com®. The teleradiology leader is providing valued members ... platform enhancing the extraordinary services already offered by ...
Breaking Medicine News(10 mins):Health News:Early Stem Cell Transplant Vital in 'Bubble Boy' Disease 2Health News:Early Stem Cell Transplant Vital in 'Bubble Boy' Disease 3Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 2Health News:New Catheter Improves Outcomes for Abnormal Heart Beat 3Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 2Health News:Bedros Keuilian’s New Post Explains the Value of Fitness Information Products in Marketing a Personal Training Business 3Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 2Health News:SECONDOPINIONS.COM® Introduces Innovative Cloud-Based Medical Imaging Exchange Service for Easy Upload, Access and Sharing Anytime/Anywhere 3
... March 3 Shopko has some groundbreaking,news for Council Bluffs. ... as well as a fifth store to the suburban Omaha ... This month, Shopko will open the first new store ... a departure from the look and layout of,current Shopko stores. ...
... Frances Barras of Nederland,Texas, along with her husband ... manufacturers because she has developed mesothelioma from,washing and ... They are represented by Dallas-based Baron & Budd, ... a refinery worker at the,Beaumont DuPont facility between ...
... attack patients have a higher risk for sudden death in ... by researchers from Washington University School of Medicine in St. ... , "There,s a two- to four-fold increase in a person,s ... happen to be depressed," says Robert. M. Carney, Ph.D., lead ...
... Park Dental, a Twin Cities area,group dental practice ... Dental,community for 40-years, announced today that it has ... practice from its Boston, Massachusetts-based,administrative services provider, American ... result of the settlement of a lawsuit in ...
... Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) announced today that ... Officer and Chairman of,the Board of Directors later this year ... said, "After 15 years at the helm of the company ... right for me to retire from this marvelous,company. Over the ...
... --- Testosterone appears to protect people against eating disorders, ... just social influences -- are linked to anorexia and ... University. , An ongoing, six-year study of 538 sets ... in the womb with male twins have lower risk ...
Cached Medicine News:Health News:Shopko Announces New Prototype Store in Council Bluffs 2Health News:Woman Sues DuPont and Asbestos Manufacturers After Developing Mesothelioma From Exposure to Asbestos in Husband's Work Clothes 2Health News:Clinical depression raises risk of death for heart attack patients years after attack 2Health News:Clinical depression raises risk of death for heart attack patients years after attack 3Health News:Park Dental Announces Separation From Its Administrative Service Provider 2Health News:Park Dental Announces Separation From Its Administrative Service Provider 3Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 2Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 3Health News:MSU research indicates testosterone could guard against eating disorders 2
... Shaker provides the exact agitation needed ... very slow to fast speed and ... a gentle wave motion that lifts ... membranes to achieve faster, more uniform ...
Conversion Kits For Modular Incubator Chamber...
Conversion Kits For Modular Incubator Chamber...
Inquire...
Medicine Products: